3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
7
Fallopian Tube Neoplasms
6
Ovarian Neoplasms
5
Neoplasms
5
Colorectal Neoplasms
5
Prostatic Neoplasms
4
Glioblastoma
4
Solitary Fibrous Tumor, Pleural
3
Mesothelioma, Malignant
3
Carcinoma, Renal Cell
3
Triple Negative Breast Neoplasms
2
Sarcoma, Alveolar Soft Part
2
Sarcoma
2
Lung Neoplasms
2
Gliosarcoma
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Uveal Melanoma
1
Thyroid cancer, Hurthle cell
1
Thyroid Cancer, Papillary
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neoplasm Metastasis
1
Melanoma
1
Leukemia, Myeloid, Acute
1
Kidney Neoplasms
1
Hypertension
1
Interventions
Doxorubicin
6
pazopanib
5
Gemcitabine
4
pembrolizumab
3
Trabectedin
3
Sorafenib
3
Docetaxel
3
Dacarbazine
3
eribulin
2
Sunitinib
2
Radiotherapy, Conformal
2
Radiotherapy
2
Nivolumab
2
Letrozole
2
Ifosfamide
2
Bevacizumab
2
tremelimumab
1
temsirolimus
1
saracatinib
1
sapanisertib
1
rucaparib
1
romidepsin
1
olaratumab
1
mocetinostat
1
liposomal doxorubicin
1
lenvatinib
1
indolepropanol phosphate
1
durvalumab
1
cixutumumab
1
cabozantinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leiomyosarcoma
×
cediranib
×
Clear all
No trials found.